The Study of add on effect of Madhusudan Vati and Arogyavardhini Vati in Prameha with special reference to Type 2 Diabetes Mellitus

Prameha (Diabetes mellitus) is an age long disease known from vedic period and now it a leading lifestyle disorder. Diabetes mellitus group of metabolic syndromes fat, protein carbohydrate which due to absolute or relative deficiency insulin, characterized by hyperglycemia over prolonged with polyuria, polydipsia, polyphagia like symptoms. The estimates in 2019 showed that 77 million individuals had diabetes India, expected rise 134 2045. It has turned out be the biggest “silent killer” today’s world. This Open label Comparative clinical study pre-test post-test design where 60 patients suffering (type 2 DM) either gender between 25 75 years were randomly selected grouped into Group A B. 30 treated Arogyavardhini vati & Madhusudhan Metformin (500 mg) Glimepiride (1mg) BD. B given (500mg) (1 for 120 days. Results obtained subjective objective parameters analyzed statistical significance adapting paired T test, unpaired Mann-Whitney Z Wilcoxon Signed Ranks Test Z. revealed was found more effective bringing symptomatic relief improving biochemical markers Prameha.